Novo Nordisk Aktie
59,12
EUR
-1,76
EUR
-2,89
%
59,42
EUR
-0,58
EUR
-0,97
%
Werbung
Novo Nordisk Aktie Analyse
23.05.23 | Novo Nordisk Buy | Deutsche Bank AG | |
22.05.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
22.05.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
05.05.23 | Novo Nordisk Buy | Deutsche Bank AG | |
05.05.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
05.05.23 | Novo Nordisk Outperform | Credit Suisse Group | |
04.05.23 | Novo Nordisk Sell | UBS AG | |
04.05.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
Werbung
|
|||
28.04.23 | Novo Nordisk Sell | UBS AG | |
27.04.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
20.04.23 | Novo Nordisk Overweight | Barclays Capital | |
18.04.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
18.04.23 | Novo Nordisk Buy | Deutsche Bank AG | |
14.04.23 | Novo Nordisk Sell | UBS AG | |
14.04.23 | Novo Nordisk Overweight | Barclays Capital | |
13.04.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
13.04.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
13.04.23 | Novo Nordisk Outperform | Credit Suisse Group | |
12.04.23 | Novo Nordisk Overweight | Barclays Capital | |
11.04.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
06.04.23 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
03.04.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
24.03.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
23.03.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
22.03.23 | Novo Nordisk Buy | Deutsche Bank AG | |
14.03.23 | Novo Nordisk Buy | Deutsche Bank AG | |
09.03.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
22.02.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
13.02.23 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
06.02.23 | Novo Nordisk Buy | Deutsche Bank AG | |
02.02.23 | Novo Nordisk Neutral | Credit Suisse Group | |
02.02.23 | Novo Nordisk Buy | Deutsche Bank AG | |
01.02.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
01.02.23 | Novo Nordisk Sell | UBS AG | |
01.02.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
25.01.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
25.01.23 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
25.01.23 | Novo Nordisk Overweight | Barclays Capital | |
20.01.23 | Novo Nordisk Sell | UBS AG | |
16.01.23 | Novo Nordisk Buy | Deutsche Bank AG | |
09.01.23 | Novo Nordisk Overweight | Barclays Capital | |
09.01.23 | Novo Nordisk Sell | UBS AG | |
05.01.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
03.01.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
23.12.22 | Novo Nordisk Overweight | Barclays Capital | |
07.12.22 | Novo Nordisk Buy | Deutsche Bank AG | |
25.11.22 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
14.11.22 | Novo Nordisk Overweight | Barclays Capital | |
08.11.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
04.11.22 | Novo Nordisk Buy | Deutsche Bank AG |
Werbung
Werbung